Pirolli, D.; Righino, B.; Tropea, B.; Gurrieri, F.; Sangiorgi, E.; Rosa, M.C.D.
In Silico Design of E3 Ubiquitin-Protein Ligase NEDD4-1 Inhibitors: An Alternative Approach for Targeting the MAPK Pathway in Cancer Therapy. Proceedings 2019, 22, 10.
https://doi.org/10.3390/proceedings2019022010
AMA Style
Pirolli D, Righino B, Tropea B, Gurrieri F, Sangiorgi E, Rosa MCD.
In Silico Design of E3 Ubiquitin-Protein Ligase NEDD4-1 Inhibitors: An Alternative Approach for Targeting the MAPK Pathway in Cancer Therapy. Proceedings. 2019; 22(1):10.
https://doi.org/10.3390/proceedings2019022010
Chicago/Turabian Style
Pirolli, Davide, Benedetta Righino, Beatrice Tropea, Fiorella Gurrieri, Eugenio Sangiorgi, and Maria Cristina De Rosa.
2019. "In Silico Design of E3 Ubiquitin-Protein Ligase NEDD4-1 Inhibitors: An Alternative Approach for Targeting the MAPK Pathway in Cancer Therapy" Proceedings 22, no. 1: 10.
https://doi.org/10.3390/proceedings2019022010
APA Style
Pirolli, D., Righino, B., Tropea, B., Gurrieri, F., Sangiorgi, E., & Rosa, M. C. D.
(2019). In Silico Design of E3 Ubiquitin-Protein Ligase NEDD4-1 Inhibitors: An Alternative Approach for Targeting the MAPK Pathway in Cancer Therapy. Proceedings, 22(1), 10.
https://doi.org/10.3390/proceedings2019022010
